History of myeloid-derived suppressor cells

James E Talmadge, Dmitry I. Gabrilovich

Research output: Contribution to journalReview article

468 Citations (Scopus)

Abstract

Tumour-induced granulocytic hyperplasia is associated with tumour vasculogenesis and escape from immunity via T cell suppression. Initially, these myeloid cells were identified as granulocytes or monocytes; however, recent studies have revealed that this hyperplasia is associated with populations of multipotent progenitor cells that have been identified as myeloid-derived suppressor cells (MDSCs). The study of MDSCs has provided a wealth of information regarding tumour pathobiology, has extended our understanding of neoplastic progression and has modified our approaches to immune adjuvant therapy. In this Timeline article, we discuss the history of MDSCs, their influence on tumour progression and metastasis, and the crosstalk between tumour cells, MDSCs and the host macroenvironment.

Original languageEnglish (US)
Pages (from-to)739-752
Number of pages14
JournalNature Reviews Cancer
Volume13
Issue number10
DOIs
StatePublished - Oct 1 2013

Fingerprint

Hyperplasia
Neoplasms
Tumor Escape
Myeloid Cells
Granulocytes
Monocytes
Immunity
Stem Cells
History
Neoplasm Metastasis
T-Lymphocytes
Myeloid-Derived Suppressor Cells
Population
Therapeutics
TimeLine

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

History of myeloid-derived suppressor cells. / Talmadge, James E; Gabrilovich, Dmitry I.

In: Nature Reviews Cancer, Vol. 13, No. 10, 01.10.2013, p. 739-752.

Research output: Contribution to journalReview article

Talmadge, James E ; Gabrilovich, Dmitry I. / History of myeloid-derived suppressor cells. In: Nature Reviews Cancer. 2013 ; Vol. 13, No. 10. pp. 739-752.
@article{14a5b7d87b134570872cf6a8a49dd242,
title = "History of myeloid-derived suppressor cells",
abstract = "Tumour-induced granulocytic hyperplasia is associated with tumour vasculogenesis and escape from immunity via T cell suppression. Initially, these myeloid cells were identified as granulocytes or monocytes; however, recent studies have revealed that this hyperplasia is associated with populations of multipotent progenitor cells that have been identified as myeloid-derived suppressor cells (MDSCs). The study of MDSCs has provided a wealth of information regarding tumour pathobiology, has extended our understanding of neoplastic progression and has modified our approaches to immune adjuvant therapy. In this Timeline article, we discuss the history of MDSCs, their influence on tumour progression and metastasis, and the crosstalk between tumour cells, MDSCs and the host macroenvironment.",
author = "Talmadge, {James E} and Gabrilovich, {Dmitry I.}",
year = "2013",
month = "10",
day = "1",
doi = "10.1038/nrc3581",
language = "English (US)",
volume = "13",
pages = "739--752",
journal = "Nature Reviews Cancer",
issn = "1474-175X",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - History of myeloid-derived suppressor cells

AU - Talmadge, James E

AU - Gabrilovich, Dmitry I.

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Tumour-induced granulocytic hyperplasia is associated with tumour vasculogenesis and escape from immunity via T cell suppression. Initially, these myeloid cells were identified as granulocytes or monocytes; however, recent studies have revealed that this hyperplasia is associated with populations of multipotent progenitor cells that have been identified as myeloid-derived suppressor cells (MDSCs). The study of MDSCs has provided a wealth of information regarding tumour pathobiology, has extended our understanding of neoplastic progression and has modified our approaches to immune adjuvant therapy. In this Timeline article, we discuss the history of MDSCs, their influence on tumour progression and metastasis, and the crosstalk between tumour cells, MDSCs and the host macroenvironment.

AB - Tumour-induced granulocytic hyperplasia is associated with tumour vasculogenesis and escape from immunity via T cell suppression. Initially, these myeloid cells were identified as granulocytes or monocytes; however, recent studies have revealed that this hyperplasia is associated with populations of multipotent progenitor cells that have been identified as myeloid-derived suppressor cells (MDSCs). The study of MDSCs has provided a wealth of information regarding tumour pathobiology, has extended our understanding of neoplastic progression and has modified our approaches to immune adjuvant therapy. In this Timeline article, we discuss the history of MDSCs, their influence on tumour progression and metastasis, and the crosstalk between tumour cells, MDSCs and the host macroenvironment.

UR - http://www.scopus.com/inward/record.url?scp=84884556145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884556145&partnerID=8YFLogxK

U2 - 10.1038/nrc3581

DO - 10.1038/nrc3581

M3 - Review article

VL - 13

SP - 739

EP - 752

JO - Nature Reviews Cancer

JF - Nature Reviews Cancer

SN - 1474-175X

IS - 10

ER -